Bristol-Myers To Pocket $1B From Lilly-ImClone Deal
Bristol-Myers Squibb’s 16.6% share of ImClone Systems will net it $1 billion in cash from Eli Lilly’s takeover deal. The gain will greatly improve Bristol’s cash position relative to Lilly. (BNET)
The Curator finds, summarizes, and links to the highest-quality, most authoritative online sources of business and political news and information: breaking news, analysis, background and opinion. Learn more »
Have something you'd like to share?
Is there an important story you think we should cover or features you would like added? Let us know »
Bristol-Myers Squibb’s 16.6% share of ImClone Systems will net it $1 billion in cash from Eli Lilly’s takeover deal. The gain will greatly improve Bristol’s cash position relative to Lilly. (BNET)
Categories: Biotech, Pharma · Business & Finance Today
No Comments Yet
You can be the first to comment!
Leave a comment